New Preprint Article – DrKF’s Latest Analysis on Furin’s Connection to SARS Cov-2 and Treatment Implications Now Available on SSRN

My research and analysis on the important connections between furin and SARS CoV-2 has been accepted as a preprint article on SSRN. Thank you, David Riley, for making that happen! Abstract: Furin is a protease that is ubiquitous in the mammalian metabolism. One of the innovations that make SARS-CoV-2 more infectious than its ancestor viruses…

Inflammation resolution is a key strategy for escalating COVID-19 symptoms – a new paper and free DrKF webinar replay

From the folks that brought us Specialized Pro-resolving Lipid Mediators (SPMs), comes a new peer-reviewed paper that highlights the potential for SPMs in addressing pro-inflammatory cytokine production and cytokine storm in COVID-19. SPMs stimulate macrophage-mediated clearance of cellular debris and reduce pro-inflammatory cytokine levels. They also promote anti-viral B cell antibodies and other white blood…

Can Unconventional Immunomodulatory Agents Help Alleviate COVID-19 Symptoms and Severity?

ABSTRACT Severe acute respiratory syndrome coronavirus 2 (SARS coronavirus 2, or SARS-CoV-2) is the cause of the respiratory infection known as COVID-19. From an immunopathological standpoint, coronaviruses such as SARS-CoV-2 induce increased levels of a variety of T-helper 1 (Th1) and inflammatory cytokines and chemokines, including interleukin-1 (IL-1), IL-6, CCL2 protein, and CXCL10 protein. In…